Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy.
Miguel Arguello-TomasPablo MozasNil AlbiolMiguel López-EstebanJorge SierraJosep NomdedéuCarolina Martinez-LapercheEsther MogaJuan A PiñeyroaJulio DelgadoSantiago OsorioCarol MorenoPublished in: Cancer (2024)
Moreover, the results suggest that IGHV2 may improve the accuracy of RS.